22 Oct
|
CA03 BioVectra
|
Montague
22 Oct
CA03 BioVectra
Montague
As a global leader in laboratory and clinical technologies, we are passionate about bringing great science to life. Our commitment to quality and innovation supports cutting-edge life science research, patient diagnostics, and ensures the safety of water, food, and pharmaceuticals. As scientists and clinicians pursue small, everyday advances and life-changing discoveries, we provide trusted answers to their most critical questions and challenges. Leveraging more than 50 years of expertise, we create advanced instruments, software, and consumables supported by teams of highly skilled and knowledgeable people. With 18,000 employees around the world, our global reach and comprehensive solutions provide the most reliable and accurate results, as well as optimal scientific, economic, and operational outcomes. We work collaboratively with our customers on their journey to make a real difference in human lives. Our culture is founded on trust, respect, and uncompromising integrity, and we pride ourselves on being a energetic and inclusive workplace that celebrates diversity and fosters innovation. We can’t wait for you to join us as we continue our mission to improve the world around us. Information about Agilent is available at Agilent.com. The Role
We are excited to announce the formation of the Agilent Advanced Therapeutics (AAT) Division, which brings together the modalities offered by the previous Nucleic Acid Solutions Division (NASD) and the acquisition of BIOVECTRA. This new division aims to align advanced manufacturing capabilities, expertise, and resources to foster greater innovation and operational excellence. As part of AAT, you will have the opportunity to work with cutting‑edge technologies and collaborate with a team of dedicated professionals committed to making a significant impact on the industry.
Join us in our mission to revolutionize advanced manufacturing and contribute to the success of this market leading CDMO. Reporting to the Vice President, Commercial the Associate Vice President (AVP), Business Development is a key member of the Executive Leadership Team responsible for building, adjusting, and successfully executing on the company’s strategic direction. The commercial scope includes all processes and resources directed to accessing new business and maximizing outcomes from existing partner relationships, identifying and fortifying a strong competitive advantage through alignment of our service offerings, and executing on the go‑to‑market strategy for matching service offerings to the ever‑changing needs of the marketplace and client base. Specifically, he / she will be responsible for driving strategic growth initiatives, expanding market presence, and forging key partnerships within the manufacturing space for several modalities. This role will focus on contract development and manufacturing (CDMO) services, leveraging Agilent’s cutting‑edge capabilities in microbial fermentation, small molecule manufacturing & purification, HPAPI, bioreagents, cell line development/banking and other large‑scale GMP manufacturing services to support biotech and pharmaceutical clients.
Key Responsibilities
Business Development & Commercial Strategy. Achieve Plan and other KPIs for AAT, Canada modalities.
Routinely provides forecasts and business updates to keep leadership informed of measures deployed to ensure attainment of quarterly/annual objectives. Develop and execute a business growth strategy for Agilent’s CDMO services including microbial fermentation (both large scale and SUF), small molecule manufacturing & purification, HPAPI, bioreagents, ADC warheads/linkers, cell line development/banking and other large‑scale GMP manufacturing services. Identify, cultivate, and secure new business opportunities with biotech and pharmaceutical companies developing nucleic acid‑based therapies. Must have established relationships with procurement, external manufacturing, and other decision‑making personnel at companies who require the above services. Lead deal negotiations, contract structuring, and strategic partnerships to drive revenue growth. Work closely with Operations, Marketing, Sales Operations, Quality, Project Management, and Development teams to develop compelling value propositions for AAT’s services out of all Canada locations. Key contributor to annual strategic plan. Market Expansion & Customer Engagement. Act as a trusted advisor to clients, understanding their unique challenges in development and manufacturing of molecules used for pre‑clinical, clinical, and commercial needs. Must have a comprehension of the technical aspects of manufacturing across AAT modalities. Develop and maintain strong relationships with key decision‑makers in biotech, pharma, and emerging gene therapy companies. Represent NASD at industry conferences, trade shows, and networking events to increase brand awareness and lead generation. Monitor industry trends, competitive landscapes, and regulatory
📌 Associate VP, Sales (Montague)
🏢 CA03 BioVectra
📍 Montague